JTK-853 is a novel, non-nucleoside Hepatitis C Virus ( HCV ) polymerase inhibitor which shows effective antiviral activity in HCV replicon cells with EC 50 s of 0.38 and 0.035 µM in genotype 1a H77 and 1b Con1 strains, respectively.
Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HCV
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。